Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

The affected products include all MiniMed 600 series and MiniMed 700 series insulin pump modelsand in particular, MiniMed ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

WARSAW — Medtronic is notifying users of MiniMed 600 and 700 series insulin pumps of an increased risk for reduced battery life and less time until shutdown after a battery alert occurs. Pumps that ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G ...

Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of its MiniMed insulin pump system. This announcement comes during ...

Medtronic plc, a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series insulin pumps ...

Recommended Reading Medtronic diabetes warning letter lifted by FDA Medtronic has notified customers that battery issues with its Minimed 600 and 700 series insulin pumps could cause the devices ...

GALWAY, Ireland - Medtronic plc (NYSE: NYSE:MDT), a global healthcare technology company, has voluntarily initiated a field action for its MiniMed™ 600 and 700 series insulin pumps. Starting ...

GALWAY, Ireland - Medtronic plc (NYSE: NYSE:MDT), a global healthcare technology company, has voluntarily initiated a field action for its MiniMed™ 600 and 700 series insulin pumps. Starting July 31, ...